Please login to the form below

Not currently logged in
Email:
Password:

Roche's Dr Hagen Pfundner elected chairman of VFA

German pharmaceutical industry association also appoints Pfizer's Dr Andreas Penk as deputy chairman

Roche's Dr Hagen Pfundner has been elected chairman of the German pharmaceutical industry association, the Verband Forschender Arzneimittelhersteller (VFA).

He succeeds Bayer's Dr Wolfgang Plischke and will serve alongside Dr Andreas Penk from Pfizer, who was confirmed as deputy chairman.

Dr Pfundner is the CEO of Roche Pharma AG, Germany and managing director of Roche Holding GmbH Germany.

One of Dr Pfundner's first tasks at the VFA will be to push for further changes to the reforms outlined last year for AMNOG – Germany's system for pharmaceutical pricing and reimbursement.

He said some “urgently necessary” amendments to the reforms were needed, including the introduction of a “benefit assessment” mechanism.

9th December 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics